The initial launch of biologics includes Axograft DBM Putty; Axograft Cancellous Crushed Allograft; Axograft Crunch Allograft; and Axograft Amniotic Membrane. The biological line is intended to complement X-spine’s line of spinal fixation products and will be used to promote spinal fusion, bone healing and wound treatment in spinal arthrodesis procedures.
More articles on devices:
What’s going on at Medtronic Spine? Innovations coming down the pipe
Medtronic’s new ACDF device designed to streamline procedures
Materialise buys OrthoView — 5 quick facts
